Intensive follow-up after colorectal cancer treatment associated with increased recurrence detection
Image: PD 1. Regular CEA testing and CT imaging found more surgically curable recurrences than no scheduled follow-up 2. Intensive ...
Tag: colon cancer
2 Minute Medicine Rewind November 24 – December 1, 2013
Image: PD In this section, we will highlight the key high-impact studies, updates, and analyses published in medicine during the ...
12-gene Recurrence Score can inform adjuvant therapy of colon cancer
Image: PD Oxaliplatin 1. The 12-gene Recurrence Score can predict recurrence risk and disease-free survival in both stage II and ...
2 Minute Medicine Rewind September 30- October 6, 2013
Image: PD In this section, we will highlight the key high-impact studies, updates, and analyses published in medicine during the ...
2 Minute Medicine Rewind September 16 – September 22, 2013
Image: PD In this section, we will highlight the key high-impact studies, updates, and analyses published in medicine during the ...
Local excision inferior to major resection in T1-2 colon cancer and T2 rectal cancer
Image: PD 1. There was no significant difference in cancer-specific survival between local tumor excision and major resection of rectal ...
RAS mutation linked with survival in metastatic colorectal cancer
Image: CC/Wiki 1. Patients with colorectal liver metastases (CLM) with a RAS gene mutation were more likely to have cancer ...
Prospective analysis supports current colorectal cancer screening guidelines
Image: PD 1. Colonoscopy and sigmoidoscopy were associated with lower incidences of distal colorectal cancer and death from colorectal cancer. ...
Fecal occult-blood testing linked with reduction in colorectal-cancer mortality
Image: PD 1. Across a 30-year follow-up period, annual and biennial fecal occult-blood testing groups had a risk of death ...
Differential response to panitumumab seen in colorectal cancer based on genotypes
Image: PD 1. Addition of panitumumab to the first-line FOLFOX4 regimen prolonged survival in patients without RAS mutations. 2. Panitumumab ...